Penn State Health

The Medical Minute: Helping young athletes return to play safely after COVID-19

3-Dec-2020 8:20 AM EST, by Penn State Health

Newswise — Young athletes in central Pennsylvania can’t wait to start basketball and wrestling season. But with the COVID-19 pandemic raging, parents wonder how their children can stay safe. And, if their child gets COVID-19, parents wonder when it’s safe for that child to get back to competitive sports.

A team of Penn State Health Milton S. Hershey Medical Center sports medicine, family medicine and pediatric cardiology practitioners have implemented new return-to-play guidelines that help providers, young athletes (ages 18 and younger), their parents and coaches find answers.

The guidelines seek to reduce the risk for myocarditis (inflammation of the heart muscle), a possible complication in serious COVID-19 cases. “Most people with myocarditis won’t have chest pain or shortness of breath, and they may feel fine at rest,” says Dr. Matthew Silvis, vice chair of clinical operations in the Department of Family and Community Medicine at Hershey Medical Center and director of primary care sports medicine for Penn State Health. “But having myocarditis increases your risk for sudden cardiac death during exercise.” Myocarditis often can be found on an electrocardiogram (EKG), a test of the heart’s electrical function.

The guidelines – based on recommendations from the American College of Cardiology, the American Medical Society for Sports Medicine and the National Federation of High School Sports – recommend that young athletes:

  • Return to play after 14 days if they had an asymptomatic or mild COVID-19 case (no fever and symptoms lasting less than three days)
  • Get a pediatric EKG if they had a moderate COVID-19 case (fever and symptoms lasting more than three days). If the EKG is normal, the athlete can return to play. If it’s abnormal or the athlete develops any cardiopulmonary symptoms, the athlete’s primary care provider should consult with a pediatric cardiologist to determine the best next steps.
  • Must not exercise for three to six months if they had a severe COVID-19 case (hospitalized or abnormal cardiac testing). The athlete’s primary care provider should consult with a pediatric cardiologist, as well.

The guidelines apply to athletes participating in school-sponsored sports, travel leagues and recreational leagues. “We define competitive as any level above and beyond the normal level of childhood play,” said Dr. Joseph Andrie, a sports medicine physician at Hershey Medical Center.

Parents can get pediatric EKGs locally at Hershey Medical Center, Penn State Children’s Hospital, Penn State Health St. Joseph Medical Center or at eight Penn State Health outpatient centers.

While the connection between myocarditis and COVID-19 remains unclear, some college athletes have shown signs of heart inflammation, according to a September article published in JAMA Cardiology. “We’re implementing our guidelines out of an abundance of caution so young athletes can increase the intensity of their exercise and know their heart is functioning normally,” Silvis said.

In addition to following their doctors’ return-to-play recommendations, youth athletes can also take these six steps to stay safe during sports this winter:

  1. Wear a mask. While outdoor fall sports didn’t require masks during competition, the Pa. Department of Health recommends athletes wear masks while participating in games, matches and practices this winter. “There is no medical evidence showing that masks impede with oxygen delivery or cause any kind of potential hazard to athletes,” Andrie said.
  1. Maintain social distancing by staying at least six feet apart on the sidelines.
  1. Wash hands frequently.
  1. Stay home when sick. Young athletes who feel any COVID-19 symptoms—or those who don’t feel well in general—should refrain from practices or games.
  1. Stay safe off the field. Remain vigilant with social distancing, handwashing and interacting with others when in locker rooms. Limit or refrain from attending social events.
  1. Stay flexible. Expect winter sports schedules to change often based on the latest COVID-19 case numbers and health guidance.

Related content:

The Medical Minute is a weekly health news feature produced by Penn State Health. Articles feature the expertise of faculty, physicians and staff, and are designed to offer timely, relevant health information of interest to a broad audience.

SEE ORIGINAL STUDY




Filters close

Showing results

110 of 4573
Released: 15-Jan-2021 5:40 PM EST
Research Links Social Isolation to COVID-19 Protocol Resistance
Humboldt State University

As health officials continue to implore the public to wear masks and practice social distancing, recent research by Humboldt State University Psychology Professor Amber Gaffney provides key insights into connections between social isolation, conspiratorial thinking, and resistance to COVID-19 protocols.

Newswise: Rapid blood test identifies COVID-19 patients at high risk of severe disease
Released: 15-Jan-2021 5:35 PM EST
Rapid blood test identifies COVID-19 patients at high risk of severe disease
Washington University in St. Louis

Scientists at Washington University School of Medicine in St. Louis have shown that a relatively simple and rapid blood test can predict which patients with COVID-19 are at highest risk of severe complications or death. The blood test measures levels of mitochondrial DNA, which normally resides inside the energy factories of cells. Mitochondrial DNA spilling out of cells and into the bloodstream is a sign that a particular type of violent cell death is taking place in the body.

Released: 15-Jan-2021 2:55 PM EST
COVID-19 deaths really are different. But best practices for ICU care should still apply, studies suggest.
Michigan Medicine - University of Michigan

COVID-19 deaths are indeed different from other lung failure deaths, according to two recent studies, with 56% of COVID-19 patients dying primarily from the lung damage caused by the virus, compared with 22% of those whose lungs fail due to other causes. But, the researchers conclude, the kind of care needed to help sustain people through the worst cases of all forms of lung failure is highly similar, and just needs to be fine-tuned.

Released: 15-Jan-2021 2:50 PM EST
45% of adults over 65 lack online medical accounts that could help them sign up for COVID-19 vaccinations
Michigan Medicine - University of Michigan

As the vaccination of older adults against COVID-19 begins across the country, new poll data suggests that many of them don’t yet have access to the “patient portal” online systems that could make it much easier for them to schedule a vaccination appointment. In all, 45% of adults aged 65 to 80 had not set up an account with their health provider’s portal system.

Released: 15-Jan-2021 1:30 PM EST
New England Journal of Medicine publishes COVID-19 treatment trial results
University of Texas at San Antonio

A clinical trial involving COVID-19 patients hospitalized at UT Health San Antonio and University Health, among roughly 100 sites globally, found that a combination of the drugs baricitinib and remdesivir reduced time to recovery, according to results published Dec. 11 in the New England Journal of Medicine.

Released: 15-Jan-2021 12:40 PM EST
DNA test can quickly identify pneumonia in patients with severe COVID-19, aiding faster treatment
University of Cambridge

Researchers have developed a DNA test to quickly identify secondary infections in COVID-19 patients, who have double the risk of developing pneumonia while on ventilation than non-COVID-19 patients.

Released: 15-Jan-2021 12:30 PM EST
Fight CRC To Present Research Findings on The Impact of COVID-19 on the Colorectal Cancer Community at 2021 GI ASCO
Fight Colorectal Cancer

Fight Colorectal Cancer presents abstract at Gastrointestinal Cancer Symposium highlighting the need to address the barriers and opportunities for care within the colorectal cancer community during the COVID-19 pandemic

Released: 15-Jan-2021 12:25 PM EST
Technion to Award Honorary Doctorate to Pfizer CEO Dr. Albert Bourla
American Technion Society

Israel's Technion will award an honorary doctorate to Pfizer CEO and Chairman Dr. Albert Bourla, for leading the development of the novel vaccine against SARS-CoV-2, the virus that causes COVID-19. The honorary doctorate will be conferred at the Technion Board of Governors meeting in November 2021.

Released: 15-Jan-2021 11:30 AM EST
UW researchers develop tool to equitably distribute limited vaccines
University of Wisconsin-Madison

Researchers at the University of Wisconsin School of Medicine and Public Health and UW Health have developed a tool that incorporates a person’s age and socioeconomic status to prioritize vaccine distribution among people who otherwise share similar risks due to their jobs.


Showing results

110 of 4573

close
2.00859